3-iodo-alpha-methyltyrosine has been researched along with Cancer of Eye in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bubeck, B; Eisenhut, M; Heimke, U; zum Winkel, K | 1 |
Bockslaff, H; Hahn, I; Kloster, G; Spitznas, M | 1 |
Bockslaff, H; Dausch, D; Hundeshagen, H; Kloster, G; Schad, K | 1 |
3 other study(ies) available for 3-iodo-alpha-methyltyrosine and Cancer of Eye
Article | Year |
---|---|
Melanoma affine radiopharmaceuticals I. A comparative study of 131I-labeled quinoline and tyrosine derivatives.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Aminoquinolines; Animals; Cricetinae; Eye Neoplasms; Iodine Radioisotopes; Male; Melanoma; Mesocricetus; Methyltyrosines; Neoplasm Transplantation; Neoplasms, Experimental; Radionuclide Imaging; Skin Neoplasms; Tissue Distribution | 1981 |
Noncontact detection of experimental amelanotic ocular melanoma with L-3-123I-iodo-alpha-methyltyrosine.
Topics: Animals; Anterior Chamber; Eye Neoplasms; Male; Melanoma; Methyltyrosines; Neoplasms, Experimental; Rabbits; Radionuclide Imaging | 1981 |
Noncontact detection of ocular melanoma with L-3-123I-iodo-alpha-methyltyrosine: first clinical results.
Topics: Aged; Eye Neoplasms; Female; Humans; Iodine Radioisotopes; Isotope Labeling; Male; Melanoma; Methods; Methyltyrosines; Middle Aged; Radionuclide Imaging | 1982 |